Medmira Capital Ltd. - Jul 22, 2021 Form 4 Insider Report for HCW Biologics Inc. (HCWB)

Role
10%+ Owner
Signature
/s/ Hing C. Wong, as Attorney-in-Fact.
Stock symbol
HCWB
Transactions as of
Jul 22, 2021
Transactions value $
$0
Form type
4
Date filed
7/23/2021, 07:32 PM
Previous filing
Jul 19, 2021
Next filing
Sep 17, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction HCWB Common Stock Conversion of derivative security $0 +2.86M $0.00 2.86M Jul 22, 2021 Direct
transaction HCWB Common Stock Conversion of derivative security $0 +731K +25.57% $0.00 3.59M Jul 22, 2021 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction HCWB Series B Redeemable Preferred Stock Conversion of derivative security $0 -2.86M -100% $0.00* 0 Jul 22, 2021 Common Stock 2.86M Direct F1
transaction HCWB Series C Redeemable Preferred Stock Conversion of derivative security $0 -731K -100% $0.00* 0 Jul 22, 2021 Common Stock 731K Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each share of the Series B Redeemable Convertible Preferred Stock automatically converted into one share of the Issuer's Common Stock, for no additional consideration at the completion of the Issuer's initial public offering. The Redeemable Convertible Preferred Stock had no expiration date.
F2 Each share of the Series C Redeemable Convertible Preferred Stock automatically converted into one share of the Issuer's Common Stock, for no additional consideration at the completion of the Issuer's initial public offering. The Redeemable Convertible Preferred Stock had no expiration date.